Financhill
Sell
35

FORR Quote, Financials, Valuation and Earnings

Last price:
$9.56
Seasonality move :
-3.45%
Day range:
$9.40 - $9.66
52-week range:
$8.50 - $20.62
Dividend yield:
0%
P/E ratio:
239.75x
P/S ratio:
0.43x
P/B ratio:
1.24x
Volume:
57.8K
Avg. volume:
72.7K
1-year change:
-47.15%
Market cap:
$182.2M
Revenue:
$432.5M
EPS (TTM):
-$4.57

FORR Analysts' Consensus Rating

The 2 analysts providing 12-month price projections for Forrester Research shares anticipate an average target of $14.00, ranging from a low estimate of $14.00 to a high estimate of $14.00. This average target implies a growth of 46.44% compared to the current stock price of $9.56.

Consensus Price Target

$14.00

Highest Price Target

$14.00

Lowest Price Target

$14.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 0

Hold 2 0 2

Sell 0 0 0
Consensus Hold -- Hold

FORR Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Archer Aviation Stock Going Up?
Why Is Archer Aviation Stock Going Up?

Archer Aviation (NYSE:ACHR) is an aviation startup that is working…

How High Will Brown Forman Stock Go?
How High Will Brown Forman Stock Go?

On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock